[SY22] Symposium 22　Future challenge of liquid biopsy for next generation cancer therapeutics
【E】

[SY22-3] Implementing ctDNA next-generation sequencing with a large panel in a precision medicine program: clinical impact for patient management

^○Italiano Antoine (Head of Precision Medicine Program Gustave Roussy Campus, Villejuif, France)